CUFFA, Bianca
 Distribuzione geografica
Continente #
AS - Asia 1.799
EU - Europa 310
NA - Nord America 166
SA - Sud America 23
AF - Africa 2
Totale 2.300
Nazione #
HK - Hong Kong 1.716
US - Stati Uniti d'America 162
DE - Germania 106
IT - Italia 62
FI - Finlandia 61
SG - Singapore 49
RU - Federazione Russa 45
CN - Cina 25
BR - Brasile 20
ES - Italia 10
IE - Irlanda 9
AT - Austria 7
CZ - Repubblica Ceca 4
GB - Regno Unito 3
MX - Messico 3
IN - India 2
KR - Corea 2
ZA - Sudafrica 2
BD - Bangladesh 1
EC - Ecuador 1
FR - Francia 1
HN - Honduras 1
JP - Giappone 1
LK - Sri Lanka 1
NL - Olanda 1
PE - Perù 1
PL - Polonia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.300
Città #
Hong Kong 1.712
Munich 102
Helsinki 45
Ashburn 27
Singapore 22
Chandler 20
Dallas 19
Naples 16
Princeton 15
Valencia 10
Beijing 7
Dublin 7
Jyväskylä 7
Milan 7
Turku 6
Ann Arbor 5
Rome 5
Tianjin 5
Brno 4
Fisciano 4
Nuremberg 4
Salerno 4
Seattle 4
Vienna 4
Castellammare di Stabia 3
Moscow 3
Turin 3
Washington 3
Andover 2
Boardman 2
Bologna 2
Brooklyn 2
Fairfield 2
Johannesburg 2
Juiz de Fora 2
Los Angeles 2
Palermo 2
Phoenix 2
Pune 2
Shanghai 2
São Paulo 2
Verona 2
Albany 1
Arequipa 1
Arienzo 1
Atlanta 1
Belo Horizonte 1
Betim 1
Brasília 1
Cambridge 1
Chesapeake 1
Cincinnati 1
Columbia 1
Concord 1
Council Bluffs 1
Dhaka 1
Divinópolis 1
Dongguan 1
Dracena 1
Inhumas 1
Itabira 1
Jacksonville 1
Jiaozuo 1
Jundiaí 1
Kandy 1
Laguna 1
Lappeenranta 1
London 1
Manchester 1
Messina 1
Mexico City 1
Miami 1
Nola 1
Orem 1
Pratápolis 1
Quirinópolis 1
Quito 1
Quận Bình Thạnh 1
Salt Lake City 1
Sant'antimo 1
Santa Clara 1
Scisciano 1
Siena 1
Sorocaba 1
Sumaré 1
São Bernardo do Campo 1
Tashkent 1
Tokyo 1
Três Marias 1
Uberlândia 1
Villaverla 1
Warsaw 1
Wilmington 1
Yubileyny 1
Totale 2.153
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 860
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 433
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 420
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 310
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 78
A case series of blastic plasmacytoid dendritic cell neoplasia 55
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 45
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 40
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 39
Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review 35
Totale 2.315
Categoria #
all - tutte 4.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 1 2 2 1 1 2 10 3 0
2021/202227 0 0 2 1 0 0 0 0 2 2 9 11
2022/202357 4 7 12 6 1 11 2 3 4 0 1 6
2023/202486 14 3 8 8 7 15 4 5 7 2 2 11
2024/2025338 8 2 0 5 18 36 114 40 57 12 13 33
2025/20261.781 616 569 596 0 0 0 0 0 0 0 0 0
Totale 2.315